• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Desmoplakin mutations in cardiac fibroblasts cause TGFβ1-mediated pathological fibrogenesis in desmoplakin cardiomyopathy via beclin-1 regulation.心肌成纤维细胞中的桥粒斑蛋白突变通过自噬相关蛋白1调控,在桥粒斑蛋白心肌病中引发转化生长因子β1介导的病理性纤维生成。
bioRxiv. 2024 Sep 9:2024.09.09.612149. doi: 10.1101/2024.09.09.612149.
2
Single-Cell RNA Sequencing Uncovers Paracrine Functions of the Epicardial-Derived Cells in Arrhythmogenic Cardiomyopathy.单细胞RNA测序揭示心外膜来源细胞在致心律失常性心肌病中的旁分泌功能。
Circulation. 2021 Jun;143(22):2169-2187. doi: 10.1161/CIRCULATIONAHA.120.052928. Epub 2021 Mar 17.
3
PANoptosis is a prominent feature of desmoplakin cardiomyopathy.全细胞程序性坏死是桥粒斑蛋白心肌病的一个显著特征。
J Cardiovasc Aging. 2023 Feb;3(1). doi: 10.20517/jca.2022.34. Epub 2023 Jan 1.
4
Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.桥粒斑蛋白心肌病,一种与典型扩张型或致心律失常性右室心肌病不同的纤维性和炎症性心肌病。
Circulation. 2020 Jun 9;141(23):1872-1884. doi: 10.1161/CIRCULATIONAHA.119.044934. Epub 2020 May 6.
5
Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation.与心律失常性心肌病相关的患者突变增强了钙蛋白酶介导的桥粒芯糖蛋白降解。
JCI Insight. 2019 Jun 13;5(14):128643. doi: 10.1172/jci.insight.128643.
6
Endometriotic mesenchymal stem cells significantly promote fibrogenesis in ovarian endometrioma through the Wnt/β-catenin pathway by paracrine production of TGF-β1 and Wnt1.子宫内膜异位间充质干细胞通过旁分泌产生转化生长因子-β1(TGF-β1)和Wnt1,经Wnt/β-连环蛋白途径显著促进卵巢子宫内膜异位囊肿中的纤维生成。
Hum Reprod. 2016 Jun;31(6):1224-35. doi: 10.1093/humrep/dew058. Epub 2016 Mar 22.
7
Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.在转化生长因子-β1(TGF-β1)诱导人心脏成纤维细胞纤维化过程中,通过靶向转化生长因子-β受体II(TGF-β R II)抑制hsa-miR-19a-3p/19b-3p的自噬
Sci Rep. 2016 Apr 21;6:24747. doi: 10.1038/srep24747.
8
Desmoplakin Cardiomyopathy: Comprehensive Review of an Increasingly Recognized Entity.桥粒斑蛋白心肌病:对一个日益被认识的疾病实体的全面综述
J Clin Med. 2023 Apr 3;12(7):2660. doi: 10.3390/jcm12072660.
9
Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy.桥粒斑蛋白突变导致的桥粒功能障碍可引起致心律失常性右室心肌病。
Circ Res. 2006 Sep 15;99(6):646-55. doi: 10.1161/01.RES.0000241482.19382.c6. Epub 2006 Aug 17.
10
The AP-1 Transcription Factor Fosl-2 Regulates Autophagy in Cardiac Fibroblasts during Myocardial Fibrogenesis.AP-1 转录因子 Fosl-2 在心肌纤维化过程中心肌成纤维细胞自噬中的调节作用。
Int J Mol Sci. 2021 Feb 13;22(4):1861. doi: 10.3390/ijms22041861.

心肌成纤维细胞中的桥粒斑蛋白突变通过自噬相关蛋白1调控,在桥粒斑蛋白心肌病中引发转化生长因子β1介导的病理性纤维生成。

Desmoplakin mutations in cardiac fibroblasts cause TGFβ1-mediated pathological fibrogenesis in desmoplakin cardiomyopathy via beclin-1 regulation.

作者信息

Wei Chuanyu, Chan Shing-Fai, Saguner Ardan M, Brunckhorst Corinna, Duru Firat, Marine Joseph E, James Cynthia A, Calkins Hugh, Judge Daniel P, Shou Weinian, Chen Huei-Sheng Vincent

出版信息

bioRxiv. 2024 Sep 9:2024.09.09.612149. doi: 10.1101/2024.09.09.612149.

DOI:10.1101/2024.09.09.612149
PMID:39314404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11418989/
Abstract

BACKGROUND

Pathological fibrosis is a major finding in cardiovascular diseases and can result in arrhythmia and heart failure. Desmosome gene mutations can lead to arrhythmogenic cardiomyopathy (ACM). Among ACM, pathogenic desmoplakin ( ) variants cause a distinctive cardiomyopathy with excessive cardiac fibrosis that could precede ventricular dysfunction. variants are also linked to other fibrotic diseases. Whether DSP plays any role in pathological fibrosis remain unknown.

METHODS

Mesenchymal stromal cells (MSCs) are resident fibroblast-like cells that are responsible for fibrogenesis in most organs, including hearts. We first used unbiased genome-wide analyses to generate cardiac fibroblasts-like, induced pluripotent stem cell-derived MSCs from normal donors and ACM patients with mutations. We then studied the fibrogenic responses of cardiac MSCs to transforming growth factor beta-1 (TGF-β1) using Western/Co-IP, autophagy assay, gene knockdowns/over-expressions, genomic analyses, mouse DSP knockdown models, immunostaining, and qPCR.

RESULTS

TGFβ1 induced excessive accumulations of vimentin (VIM)/fibrillar collagens, and over-activated fibrotic genes in mutant MSCs when compared to normal MSCs. In normal MSCs, VIMs bind to wild-type DSP during normal fibrogenesis after TGFβ1. mutant MSCs exhibited a haplo-insufficient phenotype with increased DSP-unbound VIMs that sequestered beclin-1 (BECN1) from activating autophagy and caveolin-1 (CAV1)-mediated endocytosis. Decreased autophagy caused collagen accumulations and diminished CAV1 endocytosis resulted in abnormal CAV1 plaque formation that over-activated fibrotic genes [ and fibronectin ( )] via heightened p38 activities after TGFβ1. Genome-wide analysis and DSP knockdown in mouse fibroblasts confirmed this novel role of mutations in pathological fibrosis. Overexpression of VIM-binding domains of DSP could suppress pathological fibrosis by increasing collagen autophagic degradation and decreasing fibrotic gene expressions.

CONCLUSIONS

Our data reveal that DSP deficiency in MSCs/fibroblasts leads to exaggerated fibrogenesis in DSP-cardiomyopathy by decreasing BECN1 availability for autophagy and CAV1-endocytosis. Overexpression of VIM binding domains of DSP could be a new strategy to treat pathological fibrosis.

摘要

背景

病理性纤维化是心血管疾病的主要表现,可导致心律失常和心力衰竭。桥粒基因突变可导致致心律失常性心肌病(ACM)。在ACM中,致病性桥粒斑蛋白(DSP)变异可引发一种独特的心肌病,伴有过度的心脏纤维化,且可能先于心室功能障碍出现。DSP变异还与其他纤维化疾病有关。DSP在病理性纤维化中是否发挥作用尚不清楚。

方法

间充质基质细胞(MSC)是驻留的成纤维细胞样细胞,在包括心脏在内的大多数器官的纤维化形成中起作用。我们首先使用无偏倚的全基因组分析,从正常供体和携带DSP突变的ACM患者中生成心脏成纤维细胞样的诱导多能干细胞衍生的MSC。然后,我们使用蛋白质免疫印迹/免疫共沉淀、自噬检测、基因敲低/过表达、基因组分析、小鼠DSP敲低模型、免疫染色和定量聚合酶链反应,研究心脏MSC对转化生长因子β1(TGF-β1)的纤维化反应。

结果

与正常MSC相比,TGFβ1诱导DSP突变的MSC中波形蛋白(VIM)/纤维状胶原蛋白过度积累,并过度激活纤维化基因。在正常MSC中,TGFβ1后正常纤维化过程中VIM与野生型DSP结合。DSP突变的MSC表现出单倍体不足的表型,未与DSP结合的VIM增加,这些VIM将自噬相关蛋白1(BECN1)隔离,使其无法激活自噬以及小窝蛋白1(CAV1)介导的内吞作用。自噬减少导致胶原蛋白积累,而CAV1内吞作用减弱导致异常的CAV1斑块形成,在TGFβ1后通过增强p38活性过度激活纤维化基因[Ⅰ型胶原蛋白(COL1A1)和纤连蛋白(FN1)]。小鼠成纤维细胞的全基因组分析和DSP敲低证实了DSP突变在病理性纤维化中的这一新作用。DSP的VIM结合域过表达可通过增加胶原蛋白的自噬降解和降低纤维化基因表达来抑制病理性纤维化。

结论

我们的数据表明,MSC/成纤维细胞中DSP缺乏通过减少自噬和CAV1内吞作用中BECN1的可用性,导致DSP心肌病中纤维化形成加剧。DSP的VIM结合域过表达可能是治疗病理性纤维化的新策略。